DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Mauri L, Kereiakes DJ, Normand SL. , et al.
Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions.
Am Heart J 2010;
160 (06) 1035-1041 , 1041.e1
We do not assume any responsibility for the contents of the web pages of other providers.